DLBCL,FL恶性淋巴瘤重点分析.ppt

Major subtypes , SYSUCC DLBCL 39.5 % PTCL 18.6 % NK/T 5.8 % FL 5 % MCL 2.7 % total 71.6 % * * * Actuarial survival curves for patients with indolent NHL treated at Stanford University from 1960 to 1976, 1976 to 1987, and 1987 to 1996 are essentially indistinguishable, which shows that the widespread use of single-agent or multiagent chemotherapy or combined modality therapy has not had a significant impact on the natural course of the disease.54 （斯坦福大学回顾了1960－1975，1976－1986，1987－1996年惰性淋巴瘤的生存曲线，显示无论采用何种治疗均没有明显改变该疾病的自然病